Typewriter Therapeutics reported raising $56.3 Million in an initial SEC Form D filing, from an offering of $56.3 Million
Amount Raised
$56.3 Million
Round Type
Series A
Investors
Description
Typewriter Therapeutics, Inc. has raised $56 million in Series A financing to further its development of safe and durable genetic medicines. The financing was led by AN Venture Partners and RA Capital Management, with participation from ANRI, Gemseki, and SBI US Gateway Fund. The company aims to focus on in vivo CAR T and genetic liver diseases
Quick answer
Typewriter Therapeutics raised $56.3 Million in a Series A round, dated September 2, 2026. Investors: Anri, Gemseki, SBI US Gateway Fund, AN Venture Partners and RA Capital Management.
- How much did Typewriter Therapeutics raise?
- Typewriter Therapeutics raised $56.3 Million in a Series A round on September 2, 2026.
- Who invested in Typewriter Therapeutics?
- Anri, Gemseki, SBI US Gateway Fund, AN Venture Partners and RA Capital Management are named as investors in this round.
- What does Typewriter Therapeutics do?
- Typewriter Therapeutics, Inc. is a biotech company developing safe, durable, and re-dosable genetic medicines with curative potential for patients with cancer, autoimmune diseases, and severe genetic disorders.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Typewriter Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
- seragy holding GmbH raised $13M on October 14, 2026.
- Aptadir Therapeutics raised $45M (Seed) on September 29, 2026.
- Epicrispr Biotechnologies raised $90M (Series C) on August 10, 2026.
- GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
Who to call at Typewriter Therapeutics, and when
A new round usually means Typewriter Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Typewriter Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Typewriter Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Typewriter Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Typewriter Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTypewriter Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.